comprehensive -WSS

comprehensive

author：fashion 2025-09-29 01:37:27 - browse：316

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Adults seen as increasingly susceptible to measles

WSS

Germany receives 178 compensation applications from gay servicepeople over discrimination

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Breakthrough Alzheimer’s drugs are inaccessible in rural states

No plane should take off without an EpiPen onboard

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

focus

comprehensive

focus

As demand for Covid shots wanes, Moderna seeks its next success

Germany receives 178 compensation applications from gay servicepeople over discrimination

Novavax promises a turnaround & Lilly roils the obesity market

Wegovy cuts risk of cardiovascular events by 20%, study finds

Peter Hotez and the public health issue of online harassment

Amazon expands telehealth clinic nationwide

Dobbs anniversary: the lost opportunity of abortion as health care

CDC launches VaccineFinder tool to locate Covid

Bright Health sells Medicare Advantage business to Molina

Ohioans vote in high

entertainment

EQRx, failed developer of low

CDC launches VaccineFinder tool to locate Covid

Physician groups backed by private equity giant lobby on mergers

NIH launches clinical trials and new research office for long Covid

What the airline industry can learn from medicine

National panel will explore requiring free Covid tests

explore

entertainment

leisure time

entertainment